Zim Laboratories Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 07:05 pm
11-02-2026 | 07:05 pm
ZIMLAB's Board approved Q3 & nine-month consolidated financial results for Dec 31, 2025. Revenue hit ₹108.66 Cr, PAT ₹4.40 Cr. Board also cleared investing up to $15,000 to form a wholly-owned subsidiary in Chile for LATAM expansion.
No comments yet. Be the first to comment!
